Request Sample Inquiry
Breast Cancer Therapeutics Market

Breast Cancer Therapeutics Market

Breast Cancer Therapeutics Market - Global Industry Assessment & Forecast

img
Biotechnology and Life Sciences
Number Of Pages # Pages:

149

Base Year:

2023

Date

Jun - 2024

Format:

PDF XLS PPT

Report Code:

VMR-2513

Segments Covered
  • By Therapy By Therapy Targeted Therapy, Hormonal Therapy, Chemotherapy, Immunotherapy
  • By Cancer Type By Cancer Type Hormone Receptors, HER2+
  • By Distribution Channel By Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
  • By Region By Region North America, Europe , Asia Pacific , Latin America, Middle-East & Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 27.34 Billion
Revenue 2032Revenue 2032: USD 55.18 Billion
Revenue CAGRRevenue CAGR (2024 - 2032): 8.12%
Fastest Growing Region Fastest Growing Region (2024 - 2032) Asia Pacific
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Breast Cancer Therapeutics Market - Segment Analysis
    1. Overview
    2. Global Breast Cancer Therapeutics Market, 2016 - 2028 (USD Million)
    3. Global Breast Cancer Therapeutics Market - by Therapy
      1. By Targeted Therapy
      2. By Hormonal Therapy
      3. By Chemotherapy
      4. By Immunotherapy
    4. Global Breast Cancer Therapeutics Market - by Cancer Type
      1. By Hormone Receptors
      2. By HER2+
    5. Global Breast Cancer Therapeutics Market - by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
      4. By Other Distribution Channels
    6. Global Breast Cancer Therapeutics Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Breast Cancer Therapeutics Market - Segment Analysis
    1. Overview
    2. North America Breast Cancer Therapeutics Market, 2016 - 2028 (USD Million)
    3. North America Breast Cancer Therapeutics Market, by Therapy
      1. By Targeted Therapy
      2. By Hormonal Therapy
      3. By Chemotherapy
      4. By Immunotherapy
    4. North America Breast Cancer Therapeutics Market, by Cancer Type
      1. By Hormone Receptors
      2. By HER2+
    5. North America Breast Cancer Therapeutics Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
      4. By Other Distribution Channels
    6. North America Breast Cancer Therapeutics Market, by Country
      1. U.S.
        1. U.S. Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. U.S. Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. U.S. Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
      2. Canada
        1. Canada Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. Canada Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. Canada Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
      3. Mexico
        1. Mexico Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. Mexico Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. Mexico Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
  5. Europe Breast Cancer Therapeutics Market - Segment Analysis
    1. Overview
    2. Europe Breast Cancer Therapeutics Market, 2016 - 2028 (USD Million)
    3. Europe Breast Cancer Therapeutics Market, by Therapy
      1. By Targeted Therapy
      2. By Hormonal Therapy
      3. By Chemotherapy
      4. By Immunotherapy
    4. Europe Breast Cancer Therapeutics Market, by Cancer Type
      1. By Hormone Receptors
      2. By HER2+
    5. Europe Breast Cancer Therapeutics Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
      4. By Other Distribution Channels
    6. Europe Breast Cancer Therapeutics Market, by Country
      1. Germany
        1. Germany Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. Germany Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. Germany Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
      2. UK
        1. UK Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. UK Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. UK Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
      3. France
        1. France Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. France Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. France Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
      4. Spain
        1. Spain Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. Spain Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. Spain Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
      5. Italy
        1. Italy Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. Italy Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. Italy Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
      6. BENELUX
        1. BENELUX Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. BENELUX Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. BENELUX Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
      7. Rest of Europe
        1. Rest Of Europe Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. Rest Of Europe Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. Rest Of Europe Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
  6. Asia Pacific Breast Cancer Therapeutics Market - Segment Analysis
    1. Overview
    2. Asia Pacific Breast Cancer Therapeutics Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Breast Cancer Therapeutics Market, by Therapy
      1. By Targeted Therapy
      2. By Hormonal Therapy
      3. By Chemotherapy
      4. By Immunotherapy
    4. Asia Pacific Breast Cancer Therapeutics Market, by Cancer Type
      1. By Hormone Receptors
      2. By HER2+
    5. Asia Pacific Breast Cancer Therapeutics Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
      4. By Other Distribution Channels
    6. Asia Pacific Breast Cancer Therapeutics Market, by Country
      1. China
        1. China Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. China Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. China Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
      2. Japan
        1. Japan Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. Japan Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. Japan Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
      3. India
        1. India Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. India Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. India Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
      4. South Korea
        1. South Korea Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. South Korea Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. South Korea Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
      5. South East Asia
        1. South East Asia Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. South East Asia Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. South East Asia Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. Rest of Asia Pacific Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. Rest of Asia Pacific Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
  7. Latin America Breast Cancer Therapeutics Market - Segment Analysis
    1. Overview
    2. Latin America Breast Cancer Therapeutics Market, 2016 - 2028 (USD Million)
    3. Latin America Breast Cancer Therapeutics Market, by Therapy
      1. By Targeted Therapy
      2. By Hormonal Therapy
      3. By Chemotherapy
      4. By Immunotherapy
    4. Latin America Breast Cancer Therapeutics Market, by Cancer Type
      1. By Hormone Receptors
      2. By HER2+
    5. Latin America Breast Cancer Therapeutics Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
      4. By Other Distribution Channels
    6. Latin America Breast Cancer Therapeutics Market, by Country
      1. Brazil
        1. Brazil Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. Brazil Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. Brazil Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
      2. Argentina
        1. Argentina Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. Argentina Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. Argentina Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
      3. Rest of Latin America
        1. Rest of Latin America Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. Rest of Latin America Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. Rest of Latin America Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
  8. Middle East & Africa Breast Cancer Therapeutics Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Breast Cancer Therapeutics Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Breast Cancer Therapeutics Market, by Therapy
      1. By Targeted Therapy
      2. By Hormonal Therapy
      3. By Chemotherapy
      4. By Immunotherapy
    4. Middle East & Africa Breast Cancer Therapeutics Market, by Cancer Type
      1. By Hormone Receptors
      2. By HER2+
    5. Middle East & Africa Breast Cancer Therapeutics Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
      4. By Other Distribution Channels
    6. Middle East & Africa Breast Cancer Therapeutics Market, by Country
      1. GCC Countries
        1. GCC Countries Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. GCC Countries Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. GCC Countries Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
      2. South Africa
        1. South Africa Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. South Africa Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. South Africa Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Breast Cancer Therapeutics Market, By Therapy
          1. By Targeted Therapy
          2. By Hormonal Therapy
          3. By Chemotherapy
          4. By Immunotherapy
        2. Rest of Middle East & Africa Breast Cancer Therapeutics Market, By Cancer Type
          1. By Hormone Receptors
          2. By HER2+
        3. Rest of Middle East & Africa Breast Cancer Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
          4. By Other Distribution Channels
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Pfizer Inc. (U.S.)
    2. Novartis AG (Switzerland)
    3. Roche Holdings AG (Switzerland)
    4. AstraZeneca PLC (UK)
    5. Eli Lilly and Company (U.S.)
    6. Merck & Co. Inc. (U.S.)
    7. Bristol Myers Squibb Company (U.S.)
    8. Sanofi (France)
    9. Johnson & Johnson Inc. (U.S.)
    10. AbbVie Inc. (U.S.)
    11. Gilead Sciences Inc. (U.S.)
    12. Celgene Corp. (U.S.)
    13. Eisai Co. Ltd. (Japan)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 20-Jun-2024
Innovative Collaborations and Approvals Drive Growth in Global Breast Cancer Therapeutics Market
FAQ
Frequently Asked Question

  • The global Breast Cancer Therapeutics valued at USD 27.34 Billion in 2023 and is expected to reach USD 55.18 Billion in 2032 growing at a CAGR of 8.12%.

  • The prominent players in the market are Pfizer Inc. (U.S.), Novartis AG (Switzerland), Roche Holdings AG (Switzerland), AstraZeneca PLC (UK), Eli Lilly and Company (U.S.), Merck & Co. Inc. (U.S.), Bristol Myers Squibb Company (U.S.), Sanofi (France), Johnson & Johnson Inc. (U.S.), AbbVie Inc. (U.S.), Gilead Sciences Inc. (U.S.), Celgene Corp. (U.S.), Eisai Co. Ltd. (Japan).

  • The market is project to grow at a CAGR of 8.12% between 2024 and 2032.

  • The driving factors of the Breast Cancer Therapeutics include

  • North America was the leading regional segment of the Breast Cancer Therapeutics in 2023.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy